US Stock MarketDetailed Quotes

ANTX AN2 Therapeutics

Watchlist

1.670
+0.300+21.90%

Close Nov 29 13:00 ET

1.610
-0.060-3.59%

Post 16:53 ET

49.90MMarket Cap-839P/E (TTM)

AN2 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AN2 Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

AN2 Therapeutics Earnings Reports

AN2 Therapeutics | 8-K: AN2 Therapeutics Reports Third Quarter 2024 Financial Results, Provides Important EBO-301 Update and Highlights Progress Across Boron Chemistry Pipeline

Nov 13 16:10 ET

AN2 Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13 16:08 ET

AN2 Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 13 16:21 ET

AN2 Therapeutics | 8-K: AN2 Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business and Scientific Highlights

Aug 13 16:08 ET

Analyst Rating

Updated: Nov 30, 2024

Buy

Buy
33.33%
Hold
66.67%
Sell
0.00%

Price Target

No Data

Heat List

Overall